We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Understand the latest colorectal cancer screening guidelines for average and high-risk individuals. Learn about different screening methods like colonoscopy and stool tests, their benefits, and when to get screened to detect polyps and cancer early for better outcomes.
Colorectal cancer, affecting the colon or rectum, is the third most common cancer diagnosed in both men and women in the United States, excluding skin cancers. It is also a leading cause of cancer-related deaths worldwide. However, it is also one of the most preventable and treatable cancers when detected early. Regular screening plays a pivotal role in identifying precancerous polyps before they turn into cancer, or catching cancer at an early, highly curable stage. Understanding the recommended screening guidelines is crucial for safeguarding your health. This comprehensive guide from Doctar will walk you through everything you need to know about colorectal cancer screening, from who should get screened to the various test options available.
Colorectal cancer begins in the colon or the rectum. These cancers are often grouped together because they share many similar features. Most colorectal cancers start as small, noncancerous (benign) clumps of cells called polyps. Over time, some of these polyps can become cancerous. Detecting and removing these polyps before they become malignant is the primary goal of colorectal cancer screening.
In its early stages, colorectal cancer often presents no symptoms, which is precisely why screening is so vital. When symptoms do appear, they can vary depending on the cancer's size and location. Common symptoms include:
If you experience any of these symptoms, especially if they are new or persistent, it's important to consult your doctor promptly, regardless of your age or screening status.
While the exact cause of most colorectal cancers isn't fully understood, several factors can increase your risk:
The primary reason for colorectal cancer screening is to detect the disease at its earliest, most treatable stages, or even better, to prevent it entirely. When caught early, before it has spread, the 5-year survival rate for colorectal cancer is very high. Screening tests can find precancerous polyps so they can be removed before they have a chance to turn into cancer. They can also find cancer early, when treatment is most effective.
Screening recommendations can vary slightly between different medical organizations, but generally follow similar principles. It's always best to discuss your individual risk factors and the most appropriate screening schedule with your healthcare provider.
For individuals with an average risk of colorectal cancer (meaning no personal or family history of colorectal cancer or polyps, and no symptoms), major medical organizations recommend starting regular screening at age 45.
If you have one or more risk factors for colorectal cancer, your doctor may recommend starting screening earlier than age 45 and/or undergoing more frequent screening. High-risk factors include:
For these individuals, screening might begin in their 20s or 30s, often with colonoscopy, and be performed more frequently (e.g., every 1-3 years).
There are several effective screening tests available. They generally fall into two categories: stool-based tests and visual exams.
These tests analyze stool samples for signs of cancer. They are non-invasive and can be done at home.
These tests allow doctors to look inside the colon and rectum for polyps or cancer.
Learn about potential side effects of CML treatments like TKIs, interferon, chemotherapy, and stem cell transplants. Understand what to expect and how to communicate with your doctor for effective management.
April 1, 2026

Discover essential support resources, financial aid options, and community connections for individuals navigating life with Chronic Myeloid Leukemia (CML). Find practical advice and empathetic guidance.
April 1, 2026
Explore targeted therapy for multiple myeloma. Learn how these precision treatments work, their types, potential side effects, and how they're used alongside other therapies to manage this blood cancer.
April 1, 2026